Wegovy may help people with heart disease more than Zepbound

A new study reveals the obesity drug Wegovy, from maker Novo Nordisk, may help protect the heart more than competing drug Zepbound from Eli Lilly.

September 1, 2025

Top Stories

ABC News Live Presents